Fig. 4From: Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosisTime to event onset of hypohidrosis or anhidrosis following the candidate drugs exhibit the higher ROR and  ≥ 5 reported cases collected from the FAERS database. Drugs were not shown if the incidence of adverse effects (%) less than 10 days was 0% (zonisamide, citalopram, aripiprazole, and risperidone). Data was not available for bupropion, metformin and prednisoloneBack to article page